445 related articles for article (PubMed ID: 18533256)
1. Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice.
Umathe SN; Bhutada PS; Jain NS; Shukla NR; Mundhada YR; Dixit PV
Neuropeptides; 2008 Aug; 42(4):399-410. PubMed ID: 18533256
[TBL] [Abstract][Full Text] [Related]
2. Reversal by quercetin of corticotrophin releasing factor induced anxiety- and depression-like effect in mice.
Bhutada P; Mundhada Y; Bansod K; Ubgade A; Quazi M; Umathe S; Mundhada D
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):955-60. PubMed ID: 20447436
[TBL] [Abstract][Full Text] [Related]
3. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats.
Umathe SN; Bhutada PS; Jain NS; Dixit PV; Wanjari MM
Behav Pharmacol; 2008 Jul; 19(4):308-16. PubMed ID: 18622178
[TBL] [Abstract][Full Text] [Related]
4. Blockade of intracellular calcium release induces an antidepressant-like effect in the mouse forced swimming test.
Galeotti N; Bartolini A; Ghelardini C
Neuropharmacology; 2006 Mar; 50(3):309-16. PubMed ID: 16249008
[TBL] [Abstract][Full Text] [Related]
5. Corticotropin-releasing hormone receptors mediate consensus interferon-alpha YM643-induced depression-like behavior in mice.
Yamano M; Yuki H; Yasuda S; Miyata K
J Pharmacol Exp Ther; 2000 Jan; 292(1):181-7. PubMed ID: 10604946
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute and chronic stressors and CRF in rat and mouse tests for depression.
Dunn AJ; Swiergiel AH
Ann N Y Acad Sci; 2008 Dec; 1148():118-26. PubMed ID: 19120099
[TBL] [Abstract][Full Text] [Related]
7. Leuprolide: a luteinizing hormone releasing hormone agonist attenuates ethanol withdrawal syndrome and ethanol-induced locomotor sensitization in mice.
Umathe SN; Bhutada PS; Dixit PV; Jain NS
Neuropeptides; 2008 Jun; 42(3):345-53. PubMed ID: 18280564
[TBL] [Abstract][Full Text] [Related]
8. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant-like effects of the CRF family peptides, urocortin 1, urocortin 2 and urocortin 3 in a modified forced swimming test in mice.
Tanaka M; Telegdy G
Brain Res Bull; 2008 Mar; 75(5):509-12. PubMed ID: 18355626
[TBL] [Abstract][Full Text] [Related]
10. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
[TBL] [Abstract][Full Text] [Related]
11. Receptor binding, behavioral, and electrophysiological profiles of nonpeptide corticotropin-releasing factor subtype 1 receptor antagonists CRA1000 and CRA1001.
Okuyama S; Chaki S; Kawashima N; Suzuki Y; Ogawa S; Nakazato A; Kumagai T; Okubo T; Tomisawa K
J Pharmacol Exp Ther; 1999 May; 289(2):926-35. PubMed ID: 10215672
[TBL] [Abstract][Full Text] [Related]
12. The involvement of central noradrenergic systems and corticotropin-releasing factor in defensive-withdrawal behavior in rats.
Yang XM; Gorman AL; Dunn AJ
J Pharmacol Exp Ther; 1990 Dec; 255(3):1064-70. PubMed ID: 2262892
[TBL] [Abstract][Full Text] [Related]
13. Corticotrophin-releasing factor type 2 receptor-mediated suppression of gonadotrophin-releasing hormone mRNA expression in GT1-7 cells.
Kinsey-Jones JS; Li XF; Bowe JE; Lightman SL; O'Byrne KT
Stress; 2006 Dec; 9(4):215-22. PubMed ID: 17175507
[TBL] [Abstract][Full Text] [Related]
14. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
Menzaghi F; Howard RL; Heinrichs SC; Vale W; Rivier J; Koob GF
J Pharmacol Exp Ther; 1994 May; 269(2):564-72. PubMed ID: 8182523
[TBL] [Abstract][Full Text] [Related]
15. The role of CRF receptors in anxiety and depression: implications of the novel CRF1 agonist cortagine.
Todorovic C; Jahn O; Tezval H; Hippel C; Spiess J
Neurosci Biobehav Rev; 2005; 29(8):1323-33. PubMed ID: 16099044
[TBL] [Abstract][Full Text] [Related]
16. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
Spina MG; Merlo-Pich E; Akwa Y; Balducci C; Basso AM; Zorrilla EP; Britton KT; Rivier J; Vale WW; Koob GF
Psychopharmacology (Berl); 2002 Mar; 160(2):113-21. PubMed ID: 11875628
[TBL] [Abstract][Full Text] [Related]
17. A possible participation of gonadotropin-releasing hormone in the neuroleptic and cataleptic effect of haloperidol.
Umathe SN; Wanjari MM; Manna SS; Jain NS
Neuropeptides; 2009 Jun; 43(3):251-7. PubMed ID: 19403167
[TBL] [Abstract][Full Text] [Related]
18. The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats.
McElroy JF; Ward KA; Zeller KL; Jones KW; Gilligan PJ; He L; Lelas S
Psychopharmacology (Berl); 2002 Dec; 165(1):86-92. PubMed ID: 12474122
[TBL] [Abstract][Full Text] [Related]
19. Anxiolytic-like activity of the non-selective galanin receptor agonist, galnon.
Rajarao SJ; Platt B; Sukoff SJ; Lin Q; Bender CN; Nieuwenhuijsen BW; Ring RH; Schechter LE; Rosenzweig-Lipson S; Beyer CE
Neuropeptides; 2007 Oct; 41(5):307-20. PubMed ID: 17637475
[TBL] [Abstract][Full Text] [Related]
20. Corticotropin-releasing factor in the nucleus accumbens shell induces swim depression, anxiety, and anhedonia along with changes in local dopamine/acetylcholine balance.
Chen YW; Rada PV; Bützler BP; Leibowitz SF; Hoebel BG
Neuroscience; 2012 Mar; 206():155-66. PubMed ID: 22245501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
